These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34887919)

  • 21. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
    Johanson JF; Morton D; Geenen J; Ueno R
    Am J Gastroenterol; 2008 Jan; 103(1):170-7. PubMed ID: 17916109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Schoenfeld P; Lacy BE; Chey WD; Lembo AJ; Kurtz CB; Reasner DS; Bochenek W; Tripp K; Currie MG; Fox SM; Blakesley RE; OʼDea CR; Omniewski ND; Hall ML
    Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of lubiprostone in patients with chronic constipation.
    Barish CF; Drossman D; Johanson JF; Ueno R
    Dig Dis Sci; 2010 Apr; 55(4):1090-7. PubMed ID: 20012484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial.
    Xiao YL; Dai N; He SX; Tian A; Liu S; Tian ZB; Wang XY; Li YQ; Hou XH; Fang XC; Wen ZL; Zeng WZ; Xu H; Sun MJ; Liu YL; Wu YD; Shen XZ; Liu XW; Liu L; Chen MH
    J Dig Dis; 2021 Nov; 22(11):622-629. PubMed ID: 34633753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis.
    Yang T; Wang K; Cao Y; Wen J; Wei S; Li H; Yang X; Xiao T
    BMJ Open; 2021 Feb; 11(2):e039461. PubMed ID: 33589446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC; Brenner DM; Schoenfeld PS
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of vibrating capsule in treatment of chronic idiopathic constipation: a systematic review and meta-analysis of randomized controlled trials.
    Haghbin H; Zakirkhodjaev N; Gangwani MK; Beran A; Lee-Smith W; Piper MH; Aziz M
    Transl Gastroenterol Hepatol; 2024; 9():8. PubMed ID: 38317751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States.
    Nag A; Bornheimer R; Oster G
    Drugs Context; 2020; 9():. PubMed ID: 32863841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
    Christie J; Shroff S; Shahnavaz N; Carter LA; Harrison MS; Dietz-Lindo KA; Hanfelt J; Srinivasan S
    Am J Gastroenterol; 2017 Feb; 112(2):356-364. PubMed ID: 27922028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake.
    Ozaki A; Kessoku T; Kasai Y; Takeda Y; Okubo N; Iwaki M; Kobayashi T; Yoshihara T; Honda Y; Fuyuki A; Higurashi T; Ishiki H; Taguri M; Oyamada S; Kobayashi N; Nakajima A; Ichikawa Y
    Oncologist; 2021 Oct; 26(10):e1862-e1869. PubMed ID: 34180099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    Nakajima A; Seki M; Taniguchi S
    J Gastroenterol; 2018 Apr; 53(4):525-534. PubMed ID: 28840422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapies for constipation.
    Thayalasekeran S; Ali H; Tsai HH
    World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Non-pharmacologic Auxiliary Treatments in Improving Defecation Function in Children With Chronic Idiopathic Constipation: A Systematic Review and Network Meta-analysis.
    Tang J; Li H; Tang W
    Front Pediatr; 2021; 9():667225. PubMed ID: 33987155
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.